MS-DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC
MS-DRG 846 is chemotherapy without acute leukemia as secondary diagnosis with mcc, in MDC 17 (a medical DRG), at the with-MCC (major complication or comorbidity) level. Its FY2027 relative weight is 2.5302, so a case here pays more than the average Medicare inpatient stay (weight 1.0), with a geometric mean length of stay of 5.60 days. 3 ICD-10-CM principal diagnoses group into MS-DRGs 846–848 under the CMS definitions manual; the most-searched are listed below.
FY2027 payment factors
- Relative weight
- 2.5302
- Geometric mean LOS
- 5.60
- Arithmetic mean LOS
- 7.50
- Post-acute transfer
- No
Principal diagnoses that group to MS-DRGs 846–848
From the CMS MS-DRG definitions manual’s principal-diagnosis index: 3 ICD-10-CM codes route here, and the CC/MCC status of the secondary diagnoses decides which of 846–848 the case lands in. The 3 most-searched:
The severity splits
Same base DRG, split by whether a secondary diagnosis is a CC or MCC. The last column is the weight change from MS-DRG 846.
| 846 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC | 2.5302 | |
| 847 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC | 1.3490 | -1.1812 |
| 848 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC | 0.7756 | -1.7546 |
All FY2027 MS-DRGs · MDC 17